Detalhe da pesquisa
1.
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium.
Am J Transplant
; 23(11): 1771-1780, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37532179
2.
National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers.
Clin Gastroenterol Hepatol
; 21(6): 1581-1589, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36038129
3.
AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
Liver Transpl
; 29(10): 1041-1049, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37159217
4.
Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
Gastroenterology
; 161(5): 1502-1512, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34331914
5.
The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.
Liver Transpl
; 28(3): 376-385, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34761847
6.
National experience with living donor liver transplantation for hepatocellular carcinoma.
Liver Transpl
; 28(7): 1144-1157, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35226793
7.
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
Semin Liver Dis
; 41(2): 117-127, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33788207
8.
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
J Hepatol
; 74(4): 829-837, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33188904
9.
Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
Liver Transpl
; 27(6): 818-829, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33570786
10.
National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
Hepatology
; 71(3): 943-954, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31344273
11.
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
Hepatology
; 72(5): 1654-1665, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32017165
12.
Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
AJR Am J Roentgenol
; 216(5): 1283-1290, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33703926
13.
Liver transplantation for hepatocellular carcinoma: Management after the transplant.
Am J Transplant
; 20(2): 333-347, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31710773
14.
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Liver Transpl
; 26(9): 1100-1111, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32531867
15.
Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change.
Liver Transpl
; 26(5): 662-672, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31833634
16.
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Hepatology
; 69(3): 1193-1205, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30548884
17.
Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
Am J Transplant
; 19(8): 2210-2218, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30861298
18.
Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
Liver Transpl
; 25(2): 207-216, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30246323
19.
The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
Liver Transpl
; 25(2): 228-241, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30198150
20.
Refining the approach to down-staging of HCC prior to liver transplantation: Patient selection, loco-regional treatments, and systemic therapies.
Hepatology
; 2023 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37183865